MVASI (bevacizumab-awwb)

**Product type:** Human Prescription Drug

**Active ingredient:** BEVACIZUMAB

**Strength:** 400 mg/16mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Amgen, Inc

**Marketing category:** BLA (BLA761028)

**Pharmacologic class:** Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]